AxoGen PE Ratio 2010-2024 | AXGN
Current and historical p/e ratio for AxoGen (AXGN) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. AxoGen PE ratio as of January 17, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| AxoGen PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-01-16 | 18.43 | 0.00 | |
| 2024-09-30 | 14.02 | $-0.32 | 0.00 |
| 2024-06-30 | 7.24 | $-0.38 | 0.00 |
| 2024-03-31 | 8.07 | $-0.50 | 0.00 |
| 2023-12-31 | 6.83 | $-0.52 | 0.00 |
| 2023-09-30 | 5.00 | $-0.56 | 0.00 |
| 2023-06-30 | 9.13 | $-0.56 | 0.00 |
| 2023-03-31 | 9.45 | $-0.58 | 0.00 |
| 2022-12-31 | 9.98 | $-0.68 | 0.00 |
| 2022-09-30 | 11.92 | $-0.68 | 0.00 |
| 2022-06-30 | 8.19 | $-0.75 | 0.00 |
| 2022-03-31 | 7.94 | $-0.76 | 0.00 |
| 2021-12-31 | 9.37 | $-0.65 | 0.00 |
| 2021-09-30 | 15.80 | $-0.67 | 0.00 |
| 2021-06-30 | 21.61 | $-0.54 | 0.00 |
| 2021-03-31 | 20.26 | $-0.55 | 0.00 |
| 2020-12-31 | 17.90 | $-0.60 | 0.00 |
| 2020-09-30 | 11.63 | $-0.63 | 0.00 |
| 2020-06-30 | 9.24 | $-0.73 | 0.00 |
| 2020-03-31 | 10.40 | $-0.71 | 0.00 |
| 2019-12-31 | 17.89 | $-0.74 | 0.00 |
| 2019-09-30 | 12.48 | $-0.69 | 0.00 |
| 2019-06-30 | 19.80 | $-0.66 | 0.00 |
| 2019-03-31 | 21.06 | $-0.68 | 0.00 |
| 2018-12-31 | 20.43 | $-0.60 | 0.00 |
| 2018-09-30 | 36.85 | $-0.54 | 0.00 |
| 2018-06-30 | 50.25 | $-0.49 | 0.00 |
| 2018-03-31 | 36.50 | $-0.35 | 0.00 |
| 2017-12-31 | 28.30 | $-0.30 | 0.00 |
| 2017-09-30 | 19.35 | $-0.40 | 0.00 |
| 2017-06-30 | 16.75 | $-0.42 | 0.00 |
| 2017-03-31 | 10.45 | $-0.45 | 0.00 |
| 2016-12-31 | 9.00 | $-0.46 | 0.00 |
| 2016-09-30 | 9.03 | $-0.41 | 0.00 |
| 2016-06-30 | 6.88 | $-0.44 | 0.00 |
| 2016-03-31 | 5.36 | $-0.48 | 0.00 |
| 2015-12-31 | 5.00 | $-0.52 | 0.00 |
| 2015-09-30 | 4.12 | $-0.76 | 0.00 |
| 2015-06-30 | 3.14 | $-0.84 | 0.00 |
| 2015-03-31 | 3.50 | $-0.92 | 0.00 |
| 2014-12-31 | 3.59 | $-1.00 | 0.00 |
| 2014-09-30 | 2.44 | $-0.88 | 0.00 |
| 2014-06-30 | 2.78 | $-0.94 | 0.00 |
| 2014-03-31 | 3.05 | $-1.04 | 0.00 |
| 2013-12-31 | 4.49 | $-1.11 | 0.00 |
| 2013-09-30 | 4.44 | $-1.23 | 0.00 |
| 2013-06-30 | 4.34 | $-1.18 | 0.00 |
| 2013-03-31 | 3.61 | $-0.96 | 0.00 |
| 2012-12-31 | 2.70 | $-0.84 | 0.00 |
| 2012-09-30 | 2.70 | $-0.48 | 0.00 |
| 2012-06-30 | 3.00 | $-2.88 | 0.00 |
| 2012-03-31 | 2.70 | $-2.73 | 0.00 |
| 2011-12-31 | 2.70 | $-2.33 | 0.00 |
| 2011-09-30 | 2.50 | $-2.42 | 0.00 |
| 2011-06-30 | 3.00 | $0.07 | 42.86 |
| 2011-03-31 | 2.75 | $-0.04 | 0.00 |
| 2010-12-31 | 3.49 | $-0.31 | 0.00 |
| 2010-09-30 | 3.50 | $-0.22 | 0.00 |
| 2010-06-30 | 2.99 | $-0.11 | 0.00 |
| 2010-03-31 | 3.10 | $-0.06 | 0.00 |
| 2009-12-31 | 3.29 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.794B | $0.159B |
| AxoGen, Inc. engages in developing and marketing surgical solutions for peripheral nerves. The company's portfolio of products includes Avance Nerve Graft(R), AxoGuard Nerve Connector(R), AxoGuard Nerve Protector(R), Avive Soft Tissue Membrane(R), AcroVal Neurosensory & Motor Testing System(R) and AxoTouch Two-Point Discriminator(R). It operates primarily in the United States, Canada, the United Kingdom, and other European and international countries. AxoGen Inc., formerly known as AxoGen Corp., is based in FL, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $207.434B | 25.31 |
| Intuitive Surgical (ISRG) | United States | $194.997B | 101.95 |
| Edwards Lifesciences (EW) | United States | $43.303B | 27.50 |
| Alcon (ALC) | Switzerland | $41.141B | 27.53 |
| IQVIA Holdings (IQV) | United States | $36.894B | 20.33 |
| IDEXX Laboratories (IDXX) | United States | $34.232B | 40.31 |
| DexCom (DXCM) | United States | $30.373B | 45.74 |
| Waters (WAT) | United States | $22.584B | 33.39 |
| STERIS (STE) | Ireland | $20.308B | 23.38 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.662B | 0.00 |
| Hologic (HOLX) | United States | $16.272B | 17.57 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.198B | 13.55 |
| Globus Medical (GMED) | United States | $11.856B | 30.02 |
| Sysmex ADR (SSMXY) | Japan | $11.516B | 36.11 |
| Penumbra (PEN) | United States | $9.619B | 94.22 |
| Masimo (MASI) | United States | $8.910B | 43.11 |
| Glaukos (GKOS) | United States | $8.631B | 0.00 |
| Teleflex (TFX) | United States | $8.110B | 12.93 |
| Inari Medical (NARI) | United States | $4.642B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.532B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.486B | 25.42 |
| Veracyte (VCYT) | United States | $3.219B | 96.60 |
| LivaNova (LIVN) | United Kingdom | $2.534B | 14.63 |
| Nihon Kohden (NHNKY) | Japan | $2.370B | 18.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.364B | 0.00 |
| TransMedics (TMDX) | United States | $2.309B | 73.20 |
| Elekta AB (EKTAY) | Sweden | $2.138B | 19.22 |
| Integra LifeSciences Holdings (IART) | United States | $1.683B | 8.79 |
| Alphatec Holdings (ATEC) | United States | $1.414B | 0.00 |
| RxSight (RXST) | United States | $1.347B | 0.00 |
| Artivion (AORT) | United States | $1.253B | 83.00 |
| Pulse Biosciences (PLSE) | United States | $1.136B | 0.00 |
| OPKO Health (OPK) | United States | $1.003B | 0.00 |
| Paragon 28 (FNA) | United States | $0.867B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.730B | 17.21 |
| IRadimed (IRMD) | United States | $0.717B | 38.76 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.699B | 11.88 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.650B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.592B | 0.00 |
| SiBone (SIBN) | United States | $0.575B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.575B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.498B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.476B | 25.05 |
| Treace Medical Concepts (TMCI) | United States | $0.455B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.413B | 22.38 |
| ClearPoint Neuro (CLPT) | United States | $0.405B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.367B | 0.00 |
| NeuroPace (NPCE) | United States | $0.356B | 0.00 |
| CVRx (CVRX) | United States | $0.344B | 0.00 |
| Inogen (INGN) | United States | $0.227B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.226B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.216B | 0.00 |
| Accuray (ARAY) | United States | $0.215B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.182B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.165B | 0.00 |
| Nevro (NVRO) | United States | $0.123B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.114B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.111B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.107B | 11.47 |
| LENSAR (LNSR) | United States | $0.096B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.086B | 0.00 |
| 908 Devices (MASS) | United States | $0.079B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.078B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.074B | 0.00 |
| InspireMD (NSPR) | Israel | $0.072B | 0.00 |
| Hyperfine (HYPR) | United States | $0.069B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.063B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.061B | 31.57 |
| Baird Medical Investment Holdings (BDMD) | $0.058B | 0.00 | |
| EnVVeno Medical (NVNO) | United States | $0.057B | 0.00 |
| Neuronetics (STIM) | United States | $0.052B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.050B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.044B | 0.00 |
| Spectral AI (MDAI) | United States | $0.041B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.039B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Precision Optics (POCI) | United States | $0.030B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.030B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.025B | 0.00 |
| NexGel (NXGL) | United States | $0.023B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.017B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.013B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.011B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.010B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.009B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |